TY - JOUR
T1 - Child-centred harm reduction
AU - Barrett, Damon
AU - Stoicesco, Claudia
AU - Thumath, Meaghan
AU - Maynard, Emma
AU - Turner, Russell
AU - Shirley-Bevan, Sam
AU - Kurcevič, Eliza
AU - Petersson, Frida
AU - Hasselgård-Rowe, Jennifer
AU - Giacomello, Corina
AU - Wåhlin, Ella
AU - Lines, Rick
N1 - Publisher Copyright:
© 2022
PY - 2022/11
Y1 - 2022/11
N2 - Harm reduction has become increasingly influential in drug policy and practice, but has developed primarily around adult drug use. Theoretical, practical, ethical and legal issues pertaining to children and adolescents under the age of majority – both relating to their own use and the effects of drug use among parents or within the family – are less clear. This commentary proposes a sub-field of drug policy at the intersection of harm reduction and childhood which we refer to as ‘child-centred harm reduction’. We provide a definition and conceptual model, as well as illustrative questions that emerge through a child-centred harm reduction lens. Many people in different countries are already working on these kinds of issues, whose work needs greater recognition, analysis and support. In beginning to name and define this sub-field we hope to improve this situation, and inspire further international debate, collaboration, and innovation.
AB - Harm reduction has become increasingly influential in drug policy and practice, but has developed primarily around adult drug use. Theoretical, practical, ethical and legal issues pertaining to children and adolescents under the age of majority – both relating to their own use and the effects of drug use among parents or within the family – are less clear. This commentary proposes a sub-field of drug policy at the intersection of harm reduction and childhood which we refer to as ‘child-centred harm reduction’. We provide a definition and conceptual model, as well as illustrative questions that emerge through a child-centred harm reduction lens. Many people in different countries are already working on these kinds of issues, whose work needs greater recognition, analysis and support. In beginning to name and define this sub-field we hope to improve this situation, and inspire further international debate, collaboration, and innovation.
UR - http://www.scopus.com/inward/record.url?scp=85138772142&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2022.103857
DO - 10.1016/j.drugpo.2022.103857
M3 - Article
SN - 0955-3959
VL - 109
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
M1 - 103857
ER -